Cost-effectiveness Analysis of Genetic Testing and Tailored First-Line Therapy for Patients With Metastatic Gastrointestinal Stromal Tumors

IMPORTANCE: Gastrointestinal stromal tumor (GIST) is frequently driven by oncogenic KIT variations. Imatinib targeting of KIT marked a new era in GIST treatment and ushered in precision oncological treatment for all solid malignant neoplasms. However, studies on the molecular biological traits of GI...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Sudeep, Kumar, Abhishek, Lopez, Nicole, Zhao, Beiqun, Tang, Chih-Min, Yebra, Mayra, Yoon, Hyunho, Murphy, James D., Sicklick, Jason K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522695/
https://www.ncbi.nlm.nih.gov/pubmed/32986105
http://dx.doi.org/10.1001/jamanetworkopen.2020.13565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522695/
https://www.ncbi.nlm.nih.gov/pubmed/32986105
http://dx.doi.org/10.1001/jamanetworkopen.2020.13565

Ejemplares similares